Key result
Compared to patients with no psychiatric symptoms, the comorbidity of depression and anxiety in angina pectoris patients significantly increased the risk of major cardiovascular events (HR 2.38) and noncardiac readmission (HR 2.91).
Why the study?
Little is known about the relationship between depression or anxiety and noncardiac readmission in patients with angina pectoris.
Does comorbid depression and anxiety increase the risk of MACE and readmission in patients with angina pectoris?
Cohort (n=443)
No
Does comorbid depression and anxiety increase the risk of MACE and readmission in patients with angina pectoris?
Hazard Ratio: 2.38 (95% CI 1.11–5.1)
p-value: p=0.025
Comorbid depression and anxiety significantly increase the risk of MACE and noncardiac readmission in patients with angina pectoris compared to those without psychiatric symptoms.
May warrant psychiatric screening in angina patients; hypothesis-generating for intervention trials on prognosis.
Background: Depression and anxiety are two common psychiatric problems in patients with cardiovascular disease (CVD) and are associated with poor cardiac prognosis. The comorbidity of depression and anxiety is considered to be a more severe psychological status than non-comorbid psychiatric disorders. However, little is known about the relationship between depression or anxiety and noncardiac readmission. We conducted a prospective study on the prognostic impact of depression, anxiety, and comorbidity in angina pectoris (AP) patients. Method : In this prospective study, 443 patients with AP were included in the analysis. Follow-up assessments were performed 1 year, and 2 years after patient discharges. Clinical outcomes of interest included readmission, major cardiovascular event (MACE), and composite events. Depression and anxiety symptom scores derived from the patient health questionnaire-9 (PHQ-9) and generalised anxiety disorder-7 (GAD-7) questionnaire were used to assess mood symptoms. Participants with symptom scores of ≥ 10 on both questionnaires formed the comorbidity group. Using multivariable Cox proportional hazards models to evaluate the impact of psychiatric symptoms on clinical outcomes. Results: Among all the AP patients, 271 (61.2%) had non-depression symptoms and 172 (38. 9%) were determined to have depression symptoms. As for anxiety symptoms, 316 (71.3%), and 127 (28.7%) patients had non-anxiety, and anxiety respectively. After controlling covariates, we found that patients who endured clinical depression (hazard ratio [HR] = 2.12, 95% confidence interval [CI] 1.04–4.31, p=0.038) and anxiety ([HR] 2. 65, 95% [CI] 1.12–6.30, p=0.027) had a high risk of noncardiac readmission. Compared to participants with no psychiatric symptoms, those with comorbidities of depression and anxiety presented a greater risk of MACEs ([HR] 2.38, 95% [CI] 1.11–5.10, p=0.025) and noncardiac readmission ([HR] 2.91, 95% [CI] 1.03–8.18, p=0.043) while the single-symptom group did not show any significances on all the events. Conclusion: Depression and anxiety had predictive value for noncardiac readmission among patients with AP. Furthermore, prognoses were found to be worse for patients with comorbidities of depression and anxiety than those with single psychiatric symptoms. Additional attention needs to be focused on the initial identification and long-term monitoring of psychiatric comorbidity.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2020) conducted a cohort in Angina Pectoris (n=443). Comorbid depression and anxiety vs. No psychiatric symptoms was evaluated on Major cardiovascular events (MACE) (HR 2.38, 95% CI 1.11-5.10, p=0.025). Compared to patients with no psychiatric symptoms, the comorbidity of depression and anxiety in angina pectoris patients significantly increased the risk of major cardiovascular events (HR 2.38) and noncardiac readmission (HR 2.91).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: